U.S. flag

An official website of the United States government

GTR Home > Genes

NEFL neurofilament light chain

Gene ID: 4747, updated on 1-Oct-2024
Gene type: protein coding
Also known as: NFL; NF-L; NF68; CMT1F; CMT2E; CMTDIG; PPP1R110

Summary

Neurofilaments are type IV intermediate filament heteropolymers composed of light, medium, and heavy chains. Neurofilaments comprise the axoskeleton and they functionally maintain the neuronal caliber. They may also play a role in intracellular transport to axons and dendrites. This gene encodes the light chain neurofilament protein. Mutations in this gene cause Charcot-Marie-Tooth disease types 1F (CMT1F) and 2E (CMT2E), disorders of the peripheral nervous system that are characterized by distinct neuropathies. A pseudogene has been identified on chromosome Y. [provided by RefSeq, Oct 2008]

Associated conditions

See all available tests in GTR for this gene

DescriptionTests
Charcot-Marie-Tooth disease type 1F
MedGen: C1843164OMIM: 607734GeneReviews: Not available
See labs
Charcot-Marie-Tooth disease type 2E
MedGen: C1843225OMIM: 607684GeneReviews: Not available
See labs
Charcot-Marie-Tooth disease, dominant intermediate G
MedGen: C4693509OMIM: 617882GeneReviews: Not available
See labs
Genome-wide association study of peripheral neuropathy with D-drug-containing regimens in AIDS Clinical Trials Group protocol 384.
GeneReviews: Not available

Copy number response

Description
Copy number response
Triplosensitivity

No evidence available (Last evaluated 2018-09-17)

ClinGen Genome Curation Page
Haploinsufficency

No evidence available (Last evaluated 2018-09-17)

ClinGen Genome Curation PagePubMed

Genomic context

Location:
8p21.2
Sequence:
Chromosome: 8; NC_000008.11 (24950955..24956612, complement)
Total number of exons:
4

Links

IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.